Sotera Health Company $SHC Shares Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio boosted its position in Sotera Health Company (NASDAQ:SHC) by 4.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,635 shares of the company’s stock after purchasing an additional 1,891 shares during the period. Public Employees Retirement System of Ohio’s holdings in Sotera Health were worth $541,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SHC. UMB Bank n.a. raised its stake in shares of Sotera Health by 112.8% in the 2nd quarter. UMB Bank n.a. now owns 2,635 shares of the company’s stock worth $29,000 after buying an additional 1,397 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company’s stock worth $31,000 after acquiring an additional 2,620 shares in the last quarter. Parallel Advisors LLC raised its position in Sotera Health by 124.0% in the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company’s stock worth $37,000 after acquiring an additional 1,849 shares in the last quarter. Summit Securities Group LLC acquired a new stake in Sotera Health in the 1st quarter valued at about $67,000. Finally, Farther Finance Advisors LLC boosted its position in shares of Sotera Health by 4,881.9% during the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company’s stock valued at $70,000 after purchasing an additional 6,200 shares in the last quarter. 91.03% of the stock is owned by institutional investors.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the completion of the sale, the director directly owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. This trade represents a 16.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider directly owned 450,204 shares of the company’s stock, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,126,611 shares of company stock valued at $304,273,888 in the last quarter. Company insiders own 55.12% of the company’s stock.

Sotera Health Trading Up 0.4%

NASDAQ:SHC opened at $15.95 on Monday. The stock has a market cap of $4.53 billion, a PE ratio of 199.40 and a beta of 1.82. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $16.64. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The stock’s 50-day moving average is $15.09 and its two-hundred day moving average is $12.86.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business had revenue of $294.34 million during the quarter, compared to analyst estimates of $275.81 million. During the same period in the prior year, the firm earned $0.19 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, equities research analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on SHC shares. Barclays boosted their target price on shares of Sotera Health from $17.00 to $19.00 and gave the stock an “overweight” rating in a report on Thursday. Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Sotera Health in a research report on Saturday, September 27th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.